DocumentCode
3290074
Title
Design control regulation
Author
Wong, Norman
Author_Institution
US Food & Drug Adm., Bothell, WA, USA
fYear
1996
fDate
4-6 Nov 1996
Firstpage
244
Lastpage
246
Abstract
The Food and Drug Administration will be implementing the new GMPs for Medical Devices in June 1997. One of the significant addition to the New GMPs for Medical Devices with be part 830.30 Design Controls. Since 1984, the agency has recognized the lack of Design Controls as a significant cause for device recalls. Product design is the foundation for product development and if there is a failure in the product foundation, the product can not satisfy its intended application. It is concluded that Design Control has a significant impact on the ultimate success or failure of a new product. The value added by a manufacturer dedicating greater attention to the front end design of a new product is the less likely occurrence of unanticipated problems resulting in device recalls
Keywords
biocontrol; biomedical equipment; product development; design control regulation; device recalls; medical devices; part 830.30 Design Controls; product development; product failure; product foundation; product success; unanticipated problems; Concurrent engineering; Drugs; Industrial control; Industrial training; Lakes; Manufacturing industries; Process design; Product design; Product development; Publishing;
fLanguage
English
Publisher
ieee
Conference_Titel
Northcon/96
Conference_Location
Seattle, WA
Print_ISBN
0-7803-3277-6
Type
conf
DOI
10.1109/NORTHC.1996.564900
Filename
564900
Link To Document